pirmagrel has been researched along with thromboxane b2 in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (73.08) | 18.7374 |
1990's | 7 (26.92) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chouinard, ML; Coffman, T; Hamilton, BH; Linberg, LF; Martin, LL; Pamidi, A; Rakhit, A; Simke, JP | 1 |
Burke, TA; Danchak, M; Douglas, FL; Fomsgaard, JS; Kim, YD; Myers, AK; Peppard, J; Schaffer, AV; Viswanathan, T | 1 |
Lin, L; Nasjletti, A | 1 |
Cockcroft, DW; Manning, PJ; O'Byrne, PM; Stevens, WH | 1 |
Glovsky, MM; Horvath, SJ; Morganroth, ML; Schoeneich, SO; Till, GO; Ward, PA | 1 |
Edhag, O; Gréen, K; Henriksson, P; Rasmanis, G; Vesterqvist, O | 1 |
Kadowitz, PJ; Mayeux, PR; McNamara, DB | 1 |
FitzGerald, GA; Nowak, J | 1 |
Douglas, FL; Hoover, N; Klassen, DK; Weir, MR | 1 |
Doran, JB; FitzGerald, GA; Reilly, IA; Smith, B | 1 |
Bitterman, H; Dragon, G; Lefer, AM; Phillips, GR | 1 |
Butler, KD; Shand, RA; Wallis, RB | 1 |
Lefer, AM; Mentley, R; Sun, JZ | 1 |
Decker, K; Gyufko, K; Reinke, M; Tran-Thi, TA | 1 |
Alijani, MR; Douglas, F; Foegh, ML; Helfrich, GB; Lim, K; Taher, SA; Turk, J | 1 |
Ahmed, SW; Douglas, F; Foegh, ML; Franco, K; Katz, NM; Kim, YD; Ku, E; Ng, L; Siegelman, R; Wallace, RB | 1 |
Brundage, BH; Hart, K; Kieras, K; Rich, S | 1 |
Anner, H; Hechtman, HB; Kaufman, RP; Kobzik, L; Shepro, D; Valeri, CR | 1 |
Lucchesi, BR; Rosenthal, G; Simpson, PJ; Smith, CB | 1 |
DeCampli, WM; Goodwin, D; Handen, CE; Kosek, JC; Miller, DC; Mitchell, RS | 1 |
Brigmon, L; Lawson, DL; Mehta, J; Mehta, P; Ostrowski, N | 1 |
Friehling, TD; Kelliher, GJ; Kowey, PR; MacNab, MW; O'Connor, KM; Wetstein, L | 1 |
FitzGerald, GA; Oates, JA | 1 |
Cash, WD; Chertock, H; Ku, EC; McPherson, SE; Signor, C | 1 |
Maguire, ED; Wallis, RB | 1 |
Caspi, RR; Chan, CC; Kador, PF; Li, Q; Lopez, JS; Nussenblatt, RB; Roberge, FG | 1 |
3 trial(s) available for pirmagrel and thromboxane b2
Article | Year |
---|---|
The role of thromboxane in allergen-induced asthmatic responses.
Topics: Adult; Allergens; Asthma; Bronchial Provocation Tests; Bronchoconstriction; Double-Blind Method; Female; Humans; Imidazoles; Male; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes; Time Factors | 1991 |
Preliminary observations of the acute effects of selective serum thromboxane inhibition and angiotensin converting enzyme inhibition on blood pressure and renal hemodynamics in hypertensive humans.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Clinical Trials as Topic; Female; Hemodynamics; Humans; Hypertension; Imidazoles; Kidney; Middle Aged; Potassium; Prostaglandins; Pyridines; Renin-Angiotensin System; Sodium; Thromboxane B2; Thromboxane-A Synthase | 1989 |
Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Arteriosclerosis; beta-Thromboglobulin; Epoprostenol; Female; Humans; Imidazoles; Male; Middle Aged; Platelet Aggregation; Platelet Factor 4; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1986 |
23 other study(ies) available for pirmagrel and thromboxane b2
Article | Year |
---|---|
Pharmacokinetics and biochemical efficacy of pirmagrel, a thromboxane synthase inhibitor, in renal allograft recipients.
Topics: Adult; Half-Life; Humans; Imidazoles; Infusions, Intravenous; Kidney Transplantation; Pyridines; Radioimmunoassay; Thromboxane B2; Thromboxane-A Synthase; Transplantation, Homologous | 1992 |
Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dogs; Drug Interactions; Hemodynamics; Imidazoles; Methylprednisolone; Protamines; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1992 |
Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction.
Topics: Acetylcholine; Analysis of Variance; Angiotensin II; Animals; Aorta; Aortic Coarctation; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Endothelins; Endothelium; Fatty Acids, Unsaturated; Hydrazines; Hypertension; Imidazoles; In Vitro Techniques; Indomethacin; Isometric Contraction; Male; Phenylephrine; Prostaglandin Endoperoxides, Synthetic; Pyridines; Rats; Rats, Inbred Strains; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Vasoconstriction | 1991 |
C3a57-77, a C-terminal peptide, causes thromboxane-dependent pulmonary vascular constriction in isolated perfused rat lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Blood Pressure; Complement C3a; Cyclooxygenase Inhibitors; Imidazoles; In Vitro Techniques; Indomethacin; Lung; Male; Peptide Fragments; Perfusion; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase; Vasoconstriction | 1990 |
Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Epoprostenol; Humans; Imidazoles; Male; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1990 |
Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Cattle; Coronary Vessels; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme System; Epoprostenol; Humans; Imidazoles; Intramolecular Oxidoreductases; Isomerases; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1989 |
Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man.
Topics: 6-Ketoprostaglandin F1 alpha; Bleeding Time; Blood Platelets; Blood Vessels; Epoprostenol; Gas Chromatography-Mass Spectrometry; Humans; Imidazoles; Prostaglandin Endoperoxides; Pyridines; Reference Values; Thromboxane A2; Thromboxane B2 | 1989 |
Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Cathepsin D; Drug Synergism; Drug Therapy, Combination; Imidazoles; Male; Myocardial Depressant Factor; Pyridines; Rats; Rats, Inbred Strains; Shock, Hemorrhagic; Thromboxane B2; Thromboxane-A Synthase | 1987 |
The effects of modulation of prostanoid metabolism on the thoracic platelet accumulation induced by intravenous administration of collagen in the guinea-pig.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Chromium Radioisotopes; Collagen; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Injections, Intravenous; Platelet Aggregation; Platelet Count; Prostaglandins; Pyridines; Thorax; Thromboxane B2; Thromboxanes | 1986 |
Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
Topics: Animals; Cats; Coronary Disease; Creatine Kinase; Drug Synergism; Hemodynamics; Imidazoles; Male; Myocardium; Necrosis; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Tissue Plasminogen Activator | 1988 |
Output and effects of thromboxane produced by the liver perfused with phorbol myristate acetate.
Topics: Animals; Bile; Female; Imidazoles; Kinetics; Liver; Perfusion; Prostaglandins; Pyridines; Rats; Rats, Inbred Strains; Reference Values; Sulfonamides; Tetradecanoylphorbol Acetate; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
Topics: Depression, Chemical; Graft Rejection; Humans; Imidazoles; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1988 |
Effects of CGS-13080, a thromboxane inhibitor, on pulmonary vascular resistance in patients after mitral valve replacement surgery.
Topics: 6-Ketoprostaglandin F1 alpha; Cardiopulmonary Bypass; Heart Valve Prosthesis; Hemodynamics; Humans; Hypertension, Pulmonary; Imidazoles; Mitral Valve; Postoperative Complications; Pulmonary Circulation; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Vascular Resistance | 1988 |
Thromboxane synthetase inhibition in primary pulmonary hypertension.
Topics: Adult; Epoprostenol; Female; Humans; Hypertension, Pulmonary; Imidazoles; Male; Middle Aged; Nifedipine; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1987 |
A high plasma prostaglandin to thromboxane ratio protects against renal ischemia.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzofurans; Creatinine; Evaluation Studies as Topic; Ibuprofen; Imidazoles; Ischemia; Kidney; Kidney Tubular Necrosis, Acute; Male; Methacrylates; Pyridines; Rats; Thromboxane B2; Thromboxane-A Synthase | 1987 |
Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
Topics: Animals; Blood Pressure; Collagen; Coronary Circulation; Coronary Disease; Dogs; Heart Rate; Imidazoles; Male; Platelet Aggregation; Pyridines; Thromboxane B2; Thromboxane-A Synthase | 1986 |
Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood; Cardiopulmonary Bypass; Dogs; Double-Blind Method; Drug Evaluation, Preclinical; Female; Hemodynamics; Imidazoles; Male; Platelet Count; Pyridines; Random Allocation; Thromboxane B2; Thromboxane-A Synthase; Time Factors | 1986 |
Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Calcimycin; Calcium Chloride; Collagen; Epoprostenol; Imidazoles; Indomethacin; Leukocytes; Oxidoreductases; Platelet Aggregation; Pyridines; Rabbits; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1985 |
Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
Topics: Animals; Blood Pressure; Cats; Coronary Disease; Female; Heart Rate; Imidazoles; Male; Pyridines; Thromboxane B2; Thromboxane-A Synthase; Ventricular Fibrillation | 1986 |
Selective and nonselective inhibition of thromboxane formation.
Topics: Aspirin; Blood Platelets; Collagen; Epoprostenol; Humans; Imidazoles; Male; Pyridines; Random Allocation; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Humans; Imidazoles; In Vitro Techniques; Male; Oxidoreductases; Prostaglandins E; Pyridines; Rats; Rats, Inbred Strains; Thromboxane B2; Thromboxane-A Synthase | 1983 |
In vivo redirection of prostaglandin endoperoxides into 6-keto PGF1 alpha formation by thromboxane synthetase inhibitors in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Platelets; Collagen; Imidazoles; Indoles; Indomethacin; Male; Oxidoreductases; Pyridines; Radioimmunoassay; Rats; Rats, Inbred Strains; Thrombocytopenia; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1983 |
Suppression of S-antigen-induced experimental autoimmune uveoretinitis in Lewis rats by oral administration with CGS-13080, a thromboxane synthetase inhibitor.
Topics: Animals; Antigens; Arrestin; Autoantigens; Autoimmune Diseases; Chorioretinitis; Choroid; Dinoprostone; Eye Proteins; Female; Imidazoles; Immunoglobulin G; Lymphocyte Activation; Pyridines; Rats; Rats, Inbred Lew; Retina; Thromboxane B2; Thromboxane-A Synthase | 1993 |